Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.

Rhea-AI Summary

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) will host a conference call on November 9, 2023, at 4:30 p.m. ET to review 2023 Q3 results. The call can be accessed online at ir.axdx.com. A replay will be available for 30 days. Dial-in options are also provided.

TUCSON, Ariz., Oct. 30, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, November 9, 2023, at 4:30 p.m. Eastern Time to review 2023 third quarter results.

To listen to the audio webcast online, visit ir.axdx.com. A replay of the audio webcast will be available for 30 days.

To listen by phone, dial +1.877.883.0383 and enter the Elite Entry Number: 9121489. International participants may dial +1.412.902.6506. Please dial in 10-15 minutes prior to the start of the conference.

A replay of the call will be available by telephone at +1.877.344.7529 (U.S.) or +1.412.317.0088 (International) using the replay code 6290760 until November 30, 2023.

About Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.

"Accelerate Diagnostics" and diamond shaped logos and marks are registered trademarks of Accelerate Diagnostics, Inc. Any trade, product or service name referenced in this document using the name "Accelerate" is a trademark and/or property
of Accelerate Diagnostics, Inc. All other company and product names may be trademarks, registered trademarks, or service marks of the companies with which they are associated.

For more information about the company, its products and technology, or recent publications, visit axdx.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/accelerate-diagnostics-scheduled-call-to-review-2023-third-quarter-results-301970646.html

SOURCE Accelerate Diagnostics, Inc.

FAQ

When is Accelerate Diagnostics hosting a conference call?

Accelerate Diagnostics is hosting a conference call on November 9, 2023.

What is the purpose of the conference call?

The conference call is to review Accelerate Diagnostics' 2023 Q3 results.

Where can the audio webcast be accessed?

The audio webcast can be accessed at ir.axdx.com.

How long will the replay of the audio webcast be available?

The replay of the audio webcast will be available for 30 days.

What are the dial-in numbers for the conference call?

For phone access, dial +1.877.883.0383 (U.S.) or +1.412.902.6506 (International).

What is the Elite Entry Number for phone access?

The Elite Entry Number for phone access is 9121489.

How long will the replay of the call be available by telephone?

The replay of the call will be available by telephone until November 30, 2023.

What are the dial-in numbers for the replay of the call?

For the replay of the call, dial +1.877.344.7529 (U.S.) or +1.412.317.0088 (International).

What is the replay code for the call?

The replay code for the call is 6290760.